Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | WU-CART-007 |
Trade Name | |
Synonyms | WU-CART 007|WU-CART007 |
Drug Descriptions |
WU-CART-007 are allogeneic T-lymphocytes that have been engineered to express a chimeric antigen receptor (CAR) that targets CD7, potentially resulting in killing of tumor cells expressing CD7 and inhibition of tumor growth (Blood (2021) 138 (Supplement 1): 2772). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C182072 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
WU-CART-007 | WU-CART-007 | 0 | 2 |